Todd Sone

Todd Sone is a General Partner at aMoon Fund, where he co-leads the firm's Growth team focusing on healthcare investments. Prior to this role, he served as a Managing Director at Signet Healthcare Partners and an Investment Director at the Joddes family office. Earlier in his career, Sone worked as an equity analyst covering United States pharmaceuticals for Morgan Stanley and Goldman Sachs, following his start as a strategy consultant at Mercer Management Consulting. He holds an MBA from The Wharton School and brings over 25 years of experience to his board roles at companies including Ultima Genomics, Scipher Medicine, and Theranica. Sone previously directed investments in Arbor Pharmaceuticals, which was acquired by KKR, and Claris Lifesciences, which sold to Baxter. His current focus remains on providing growth capital to commercial-stage healthcare and life sciences companies.